Michael H. Davidson - 01 Jan 2024 Form 4 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role
Chief Executive Officer, Director
Signature
/s/ Louise Kooij by Power of Attorney from Michael H. Davidson
Issuer symbol
NAMS
Transactions as of
01 Jan 2024
Net transactions value
$0
Form type
4
Filing time
03 Jan 2024, 17:14:52 UTC
Previous filing
25 Jan 2024
Next filing
27 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAMS Option (right to buy) Award $0 +1,039,939 $0.000000 1,039,939 01 Jan 2024 Ordinary Shares 1,039,939 $11.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option will vest on January 1, 2025, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.